BANZEL Patient Assistance Program

The BANZEL Patient Assistance Program is for patients who are unable to afford their prescriptions and who meet specific financial and other eligibility criteria.

This includes patients who do not have insurance or other third-party payor prescription coverage, including Medicaid, Medicare, or managed care coverage.

For more information, including program eligibility requirements, please call 1-888-796-1234.

Fax: 1-888-430-9818

Hours: Monday-Friday, 7:00 AM-5:30 PM (Central Time).

To report suspected adverse reactions, contact Eisai Inc. at 1-888-274-2378 or the FDA at 1-800-FDA-1088 or www.FDA.gov/medwatch.

  • BANZEL: A Video Series BANZEL: A Video Series

    BANZEL®: A Video Series

    See how families are taking on LGS, from symptoms and diagnosis to treatment.

    WATCH NOW

    BANZEL®: A Video Series

    See how families are taking on LGS, from symptoms and diagnosis to treatment.

  • BANZEL ConnectionsBANZEL Connections

    BANZEL Connections

    Get information from experts to help you care for someone with LGS.

    BANZEL Connections

    Get information from experts
    to help you care for someone
    with LGS.

    ENROLL NOW

  • About BANZEL

    About BANZEL

    BANZEL (rufinamide) is a prescription medication approved for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older, and in adults.

    About BANZEL

    BANZEL (rufinamide) is a prescription medication approved for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older, and in adults.

    Find out more